2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid

C68H79F2N15O13S2 — CID 166740047

IUPAC2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
SMILESC[C@@]12CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)CNC(=O)[C@@H](CCCN)NC(=O)CCSCc1cccc(c1)CSC[C@@H](C(N)=O)NC2=O
InChIInChI=1S/C68H79F2N15O13S2/c1-68-17-4-19-85(68)66(97)55(22-37-8-12-45(86)13-9-37)83-64(95)53(27-44-31-73-36-77-44)81-65(96)54(28-59(89)90)82-63(94)52(24-41-30-75-49-15-11-43(70)26-47(41)49)80-62(93)51(23-40-29-74-48-14-10-42(69)25-46(40)48)79-58(88)32-76-61(92)50(7-3-18-71)78-57(87)16-20-99-33-38-5-2-6-39(21-38)34-100-35-56(60(72)91)84-67(68)98/h2,5-6,8-15,21,25-26,29-31,36,50-56,74-75,86H,3-4,7,16-20,22-24,27-28,32-35,71H2,1H3,(H2,72,91)(H,73,77)(H,76,92)(H,78,87)(H,79,88)(H,80,93)(H,81,96)(H,82,94)(H,83,95)(H,84,98)(H,89,90)/t50-,51+,52+,53+,54+,55+,56+,68+/m1/s1
InChIKeyIIACQYHQRJCFAR-VOORRXRHSA-N
MW1416.60 g/mol
LogP1.79
Rot. Bonds14

About 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid

2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (PubChem CID 166740047) has the molecular formula C68H79F2N15O13S2 and a molecular weight of 1416.60 g/mol. Its IUPAC name is 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.

Molecular Properties

Compound Name2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
PubChem CID166740047
Molecular FormulaC68H79F2N15O13S2
Molecular Weight1416.60 g/mol
Exact Mass1415.54
IUPAC Name2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
SMILESC[C@@]12CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)CNC(=O)[C@@H](CCCN)NC(=O)CCSCc1cccc(c1)CSC[C@@H](C(N)=O)NC2=O
InChIInChI=1S/C68H79F2N15O13S2/c1-68-17-4-19-85(68)66(97)55(22-37-8-12-45(86)13-9-37)83-64(95)53(27-44-31-73-36-77-44)81-65(96)54(28-59(89)90)82-63(94)52(24-41-30-75-49-15-11-43(70)26-47(41)49)80-62(93)51(23-40-29-74-48-14-10-42(69)25-46(40)48)79-58(88)32-76-61(92)50(7-3-18-71)78-57(87)16-20-99-33-38-5-2-6-39(21-38)34-100-35-56(60(72)91)84-67(68)98/h2,5-6,8-15,21,25-26,29-31,36,50-56,74-75,86H,3-4,7,16-20,22-24,27-28,32-35,71H2,1H3,(H2,72,91)(H,73,77)(H,76,92)(H,78,87)(H,79,88)(H,80,93)(H,81,96)(H,82,94)(H,83,95)(H,84,98)(H,89,90)/t50-,51+,52+,53+,54+,55+,56+,68+/m1/s1
InChIKeyIIACQYHQRJCFAR-VOORRXRHSA-N
XLogP1.79
TPSA440.01 Ų
H-Bond Donors15
H-Bond Acceptors16
Rotatable Bonds14
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001416.60
LogP ≤ 51.79
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1016

Analyze 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (CID 166740047) is 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.
What is the SMILES notation for 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The canonical SMILES for 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is C[C@@]12CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)CNC(=O)[C@@H](CCCN)NC(=O)CCSCc1cccc(c1)CSC[C@@H](C(N)=O)NC2=O.
What is the InChIKey of 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The InChIKey is IIACQYHQRJCFAR-VOORRXRHSA-N. The full InChI is InChI=1S/C68H79F2N15O13S2/c1-68-17-4-19-85(68)66(97)55(22-37-8-12-45(86)13-9-37)83-64(95)53(27-44-31-73-36-77-44)81-65(96)54(28-59(89)90)82-63(94)52(24-41-30-75-49-15-11-43(70)26-47(41)49)80-62(93)51(23-40-29-74-48-14-10-42(69)25-46(40)48)79-58(88)32-76-61(92)50(7-3-18-71)78-57(87)16-20-99-33-38-5-2-6-39(21-38)34-100-35-56(60(72)91)84-67(68)98/h2,5-6,8-15,21,25-26,29-31,36,50-56,74-75,86H,3-4,7,16-20,22-24,27-28,32-35,71H2,1H3,(H2,72,91)(H,73,77)(H,76,92)(H,78,87)(H,79,88)(H,80,93)(H,81,96)(H,82,94)(H,83,95)(H,84,98)(H,89,90)/t50-,51+,52+,53+,54+,55+,56+,68+/m1/s1.
What are the key properties of 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid has a molecular weight of 1416.60 g/mol, XLogP of 1.79, 14 rotatable bonds, 15 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5R,8S,14S,17S,20S,23S,26S,32R)-32-(3-aminopropyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is sourced from PubChem (CID 166740047), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).